申请人:Bayer Aktiengesellschaft
公开号:US05364942A1
公开(公告)日:1994-11-15
Sulphonylbenzyl-substituted imidazopyridines can be prepared by reacting correspondingly substituted imidazopyridines with sulphonylbenzyl compounds. The sulphonylbenzyl-substituted imidazopyridines can be employed as active compounds in medicaments, in particular for the treatment of hypertension and atherosclerosis.
磺酰苯基取代的咪唑吡啶可以通过将相应取代的咪唑吡啶与磺酰苯基化合物反应制备而成。这些磺酰苯基取代的咪唑吡啶可以作为药物中的活性化合物,特别用于治疗高血压和动脉粥样硬化。